MILFORD, Conn.--(BUSINESS WIRE)--Kubtec, the foremost developer of digital specimen radiography systems, marks the start of Breast Cancer Awareness Month with the announcement of U.S. FDA approval of MOZART® with TomoSpec®, the first and only breast specimen radiography system with tomosynthesis technology. In providing the most comprehensive analysis of excised breast tissue in a specimen radiography system, MOZART can help reduce re-excision and patient call back rates. The speed and method with which the high resolution image slices are acquired mean shorter surgeries and less anesthesia time for the patient, lowering the risk of infection in hospitals.
“MOZART with TomoSpec allows 3D margin assessment in one step, without turning and repositioning the specimen container,” said Vikram Butani, President of Kubtec. “The system captures an entire data set in less time than it takes to acquire multiple 2D images. This is critical for delivering a higher level of care to women undergoing surgery for breast cancer.”
Help employers find you! Check out all the jobs and post your resume.
